| Durvalumab, Tremelimumab and Hypofractionated Radiation Therapy in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT03522584) | University of Washington | 2018-05-17 |
| Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer (NCT03081858) | Lipac Oncology LLC | 2018-05-17 |
| Transcutaneous Vagus Nerve Stimulation for Motor Recovery After Stroke (NCT03292159) | Massachusetts General Hospital | 2018-05-17 |
| Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B (NCT04357600) | PT. Prodia Stem Cell Indonesia | 2018-05-17 |
| Vemurafenib Plus Cobimetinib in Advanced or Metastatic Melanoma Patients (NCT03224208) | Fondazione Melanoma Onlus | 2018-05-17 |
| Safety Study and Preliminary Efficacy of Infusion Haploidentical Mesenchymal Stem Cells Derived From Bone Marrow for Treating Recessive Dystrophic Epidermolysis Bullosa (NCT04153630) | Instituto de Investigación Hospital Universitario La Paz | 2018-05-17 |
| Does Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Paclitaxel? (NCT03570437) | University of Manchester | 2018-05-17 |
| Ready to Use Therapeutic Food (RUTF) to Promote Growth in Cystic Fibrosis (NCT03462056) | Washington University School of Medicine | 2018-05-17 |
| The Role of Ruxolitinib in Secondary Acute Myelogenous Leukemia Evolving From Myeloproliferative Neoplasm (NCT03558607) | Seoul National University Hospital | 2018-05-17 |
| Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-Tazobactam (NCT03485950) | M.D. Anderson Cancer Center | 2018-05-16 |
| Controlled Comparison of a Traditional Dressing Versus a Biologic Dressing Composed of Fetal Fibroblasts and Keratinocytes in Association With a Collagen Matrix on Skin Donor Sites (NCT03334656) | Nantes University Hospital | 2018-05-16 |
| Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery (NCT03510208) | Stanford University | 2018-05-16 |
| A Study of BI-1206 in Combination With Rituximab With or Without Acalabrutinib in Subjects With Indolent B-Cell NHL (NCT03571568) | BioInvent International AB | 2018-05-16 |
| Exploration of Gemfibrozil as a Treatment for AUD (NCT03539432) | The Mind Research Network | 2018-05-16 |
| VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2 (NCT03499795) | Inovio Pharmaceuticals | 2018-05-15 |
| Outcome of Steroid Therapy for Myocardial Inflammation in Scleroderma (NCT03607071) | Khon Kaen University | 2018-05-15 |
| Anti-shivering Effect of Ondansetron (NCT03530007) | Assiut University | 2018-05-15 |
| A Feasibility Study of Niraparib for Advanced, BRCA1-like, HER2-negative Breast Cancer Patients (NCT02826512) | The Netherlands Cancer Institute | 2018-05-15 |
| A Study of the Effect of Blood Stem Cell Transplant After Chemotherapy Alone in Patients With Fanconi Anemia (NCT03600909) | Memorial Sloan Kettering Cancer Center | 2018-05-15 |
| Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma (NCT03522298) | Kazia Therapeutics Limited | 2018-05-15 |
| A Study of Niclosamide Enemas in Subjects With Active Ulcerative Proctitis or Ulcerative Proctosigmoiditis (NCT03521232) | Entero Therapeutics | 2018-05-15 |
| Reduction of Zygomatic Arch in Zygomaticomaxillary Fractures (NCT04218058) | Alexandria University | 2018-05-15 |
| PSMA-PET Guided Radiotherapy (NCT03525288) | Centre hospitalier de l'Université de Montréal (CHUM) | 2018-05-15 |
| Durvalumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer (NCT02966587) | University of Washington | 2018-05-15 |
| Neoadjuvant and Adjuvant Durvalumab in Combination With Neoadjuvant Chemotherapy in Patients With Operable Urothelial Cancer. (NCT03406650) | Swiss Cancer Institute | 2018-05-15 |
| Reversing Epigenetic & Other Markers of Senescence by Transfusing Young Plasma To Older Human Subjects (NCT03353597) | Chandra Duggirala | 2018-05-15 |
| Bortezomib and Pegylated Liposomal Doxorubicin in BRCA Wild-type Platinum-resistant Recurrent Ovarian Cancer Patients (NCT03509246) | Seoul National University Hospital | 2018-05-15 |
| Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma (NCT03541902) | M.D. Anderson Cancer Center | 2018-05-15 |
| Azacitidine and Venetoclax as Induction Therapy With Venetoclax Maintenance in the Elderly With AML (NCT03466294) | University of Colorado, Denver | 2018-05-15 |
| Effects of Probiotic on Inflammation and Microbiota in Patients With NASH (NCT03511365) | Northwell Health | 2018-05-15 |
| LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Intra-abdominal Infection (cIAI) (NCT03354754) | Novartis Pharmaceuticals | 2018-05-15 |
| Pilot Study of Dapansutrile Capsules in Schnitzler's Syndrome (NCT03595371) | Olatec Therapeutics, Inc. | 2018-05-15 |
| Role of Antibiotics Post Tonsillectomy (NCT03491085) | Assiut University | 2018-05-15 |
| Follow up Study 5-6 Years After ILIT With 2 Concomitant Allergens, Birch and Grass (NCT04296474) | Lars Olaf Cardell | 2018-05-15 |
| Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma (NCT03467516) | Udai Kammula | 2018-05-14 |
| Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy (NCT03570827) | Mayo Clinic | 2018-05-14 |
| Study of Durvalumab (MEDI4736) After Chemo-Radiation for Microsatellite Stable Stage II-IV Rectal Cancer (NCT03102047) | NSABP Foundation Inc | 2018-05-14 |
| Trial in Patients With Relapsed Ovarian Cancer (NCT03267589) | Nordic Society of Gynaecological Oncology - Clinical Trials Unit | 2018-05-14 |
| Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling (NCT03412643) | NSABP Foundation Inc | 2018-05-14 |
| MTBVAC Study in Adults With and Without Latent Tuberculosis Infection in South Africa (NCT02933281) | International AIDS Vaccine Initiative | 2018-05-14 |
| A Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma (NCT03384654) | Janssen Research & Development, LLC | 2018-05-14 |
| A Trial to Investigate the Efficacy and Safety of FE 999302 as add-on Treatment to Follitropin Delta (REKOVELLE) in Women Undergoing Controlled Ovarian Stimulation. (NCT03564509) | Ferring Pharmaceuticals | 2018-05-14 |
| A Phase 2 Clinical Trial Examining the Effects on Osteoarthritic Knee Pain of CGS-200-1, CGS-200-5 and Vehicle Control (NCT03528369) | Propella Therapeutics | 2018-05-14 |
| Does Cediranib Prevent Bowel Perforation in Platinum-resistant Ovarian Cancer (NCT07648745) | Prof Gordon Jayson | 2018-05-14 |
| Coversin in PNH in Patients With Resistance to Eculizumab Due to Complement C5 Polymorphisms (NCT03427060) | AKARI Therapeutics | 2018-05-14 |
| Efficacy and Safety of Obinutuzumab Preemptive Treatment at the Time of the Molecular Relapse (NCT03229382) | Polish Lymphoma Research Group | 2018-05-14 |
| Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer (NCT03482102) | Massachusetts General Hospital | 2018-05-14 |
| CD19 T-CAR for Treatment of Children and Young Adults With r/r B-ALL (NCT03467256) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2018-05-14 |
| Evaluation of Safety and Efficacy in BEY1107 in Monotherapy Gemcitabine Combination in Patient with Pancreatic Cancer (NCT03579836) | BeyondBio Inc. | 2018-05-14 |
| Herbal Patch for Overactive Bladder (NCT03532789) | En Chu Kong Hospital | 2018-05-14 |
| Ruxolitinib for Premalignant Breast Disease (NCT02928978) | Julie Nangia | 2018-05-13 |
| Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events(TRACE) (NCT04676659) | Beijing Tiantan Hospital | 2018-05-12 |
| A Study of the Use of Hepatitis C Positive Donors for Hepatitis C Negative Lung Transplant Recipients With Post-transplant Treatment With Mavyret (NCT03523871) | NYU Langone Health | 2018-05-12 |
| Organ Preservation in Early Rectal Cancer Patients (NCT03548961) | Fox Chase Cancer Center | 2018-05-11 |
| Building Sentences With Preschoolers Who Use AAC (NCT03538925) | University of Central Florida | 2018-05-11 |
| Safety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing With 25 mg or 50 mg Daily of REL-1017 in MDD (NCT03051256) | Relmada Therapeutics, Inc. | 2018-05-11 |
| Treatment of Acute Pericarditis With Anakinra (NCT03224585) | Virginia Commonwealth University | 2018-05-11 |
| Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Treating Pediatric Patients With Positive Cytomegalovirus Undergoing Donor Stem Cell Transplant (NCT03354728) | City of Hope Medical Center | 2018-05-11 |
| Gene Therapy With Modified Autologous Hematopoietic Stem Cells for the Treatment of Patients With Mucopolysaccharidosis Type I, Hurler Variant (NCT03488394) | Orchard Therapeutics | 2018-05-11 |
| Mindfulness-Based Trauma Recovery for Refugees (MBTR-R) (NCT04380259) | University of Haifa | 2018-05-10 |
| Roflumilast in Non-CF Bronchiectasis Study (NCT03428334) | The University of Hong Kong | 2018-05-10 |
| Statins for the Primary Prevention of Heart Failure in Patients Receiving Anthracycline Pilot Study (NCT03186404) | University Health Network, Toronto | 2018-05-10 |
| Gemcitabine + Carboplatin + Nivolumab Versus Gemcitabine + Oxaliplatin + Nivolumab in Cisplatin-ineligible Patients With Metastatic Urothelial Cancer (NCT03451331) | Matthew Galsky | 2018-05-10 |
| Tocilizumab for the Treatment of Refractory Behcet's Uveitis (NCT03554161) | Wenjie Zheng | 2018-05-10 |
| Skin Toxicity in Patients With Metastatic Colorectal Cancer Treated With Anti-EGFR and Chemotherapy (DERMIA) (NCT03448731) | Fundacion CRIS de Investigación para Vencer el Cáncer | 2018-05-10 |
| Effects of Hyperbaric Oxygen (HBO) on Blood Count Recovery After Autologous Hematopoietic Stem Cell (HSPC) Transplant for Multiple Myeloma (NCT03398200) | Omar Aljitawi | 2018-05-10 |
| Study to Evaluate the Safety & Tolerability of MRT5005 Administered by Nebulization in Adults With Cystic Fibrosis (NCT03375047) | Sanofi | 2018-05-10 |
| Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer (NCT03444844) | Five Eleven Pharma, Inc. | 2018-05-10 |
| Standard of Care Therapy With Involved Field Radiation Therapy for Selective Recurrent Ovarian Cancer (NCT03618706) | Yonsei University | 2018-05-10 |
| A Study to Evaluate Safety and Immunogenicity of the ExPEC4V Clinical Trial Material After a Single Intramuscular Dose and a Second Dose 6 Months Later in Healthy Participants Aged 18 Years and Older (NCT03500679) | Janssen Research & Development, LLC | 2018-05-09 |
| Bempedoic Acid + Ezetimibe Fixed-Dose Combination (FDC) Study in Patients With Type 2 Diabetes and Elevated LDL-C (NCT03531905) | Esperion Therapeutics, Inc. | 2018-05-09 |
| Assess the Safety and Efficacy of CsA Ophthalmic Gel in Subjects With Dry Eye (NCT03676335) | Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. | 2018-05-09 |
| Atezolizumab, Rituximab, Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory DLBCL Not Suitable for High-dose Therapy (NCT03422523) | University Hospital Southampton NHS Foundation Trust | 2018-05-09 |
| BARDA Securing Anthrax Immunity For the Elderly (NCT03518125) | Biomedical Advanced Research and Development Authority | 2018-05-09 |
| Cannabidiol Oral Solution for the Treatment of Patients With Prader-Willi Syndrome (NCT02844933) | Radius Pharmaceuticals, Inc. | 2018-05-09 |
| Can DFN-15 Terminate Migraine With Allodynia? (NCT03472378) | Hartford Hospital | 2018-05-09 |
| ADI-PEG 20 in Combination With Gemcitabine and Docetaxel for the Treatment of Soft Tissue Sarcoma, Osteosarcoma, Ewing's Sarcoma, and Small Cell Lung Cancer (NCT03449901) | Washington University School of Medicine | 2018-05-09 |
| Icotinib as Consolidation Therapy After Chemoradiotherapy in EGFR-Mutant Stage IIIA-IIIB Non-small Cell Lung Cancer (NCT03396185) | Betta Pharmaceuticals Co., Ltd. | 2018-05-09 |
| Short Course Regimens for Treatment of PKDL (Sudan) (NCT03399955) | Drugs for Neglected Diseases | 2018-05-09 |
| Study of MEDI0382 in Combination With Dapagliflozin and Metformin in Overweight/Obese Participants With Type 2 Diabetes (NCT03444584) | MedImmune LLC | 2018-05-08 |
| Study of Fruquintinib (HMPL-013) in High Risk Patients With Advanced NSCLC (NCT03684967) | Hutchison Medipharma Limited | 2018-05-08 |
| Phase II Study of Concurrent Sorafenib and Intensity-modulated Radiotherapy (IMRT) for Advanced Hepatocellular Carcinoma (NCT03535259) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2018-05-08 |
| Safety, Efficacy, PD of FE203799 in Short Bowel Syndrome on Parenteral Support (NCT03415594) | GlyPharma Therapeutics | 2018-05-08 |
| Oleclumab (MEDI9447) Epidermal Growth Factor Receptor Mutant (EGFRm) Non-small Cell Lung Cancer (NSCLC) Novel Combination Study (NCT03381274) | MedImmune LLC | 2018-05-08 |
| Comparison of the Cognitive and Motor Effects of Treatment Between an Immediate- and Extended-release Tacrolimus (Envarsus® XR) Based Immunosuppression Regimen in Kidney Transplant Recipients (NCT03437577) | University of Minnesota | 2018-05-08 |
| An Open-Label Phase lB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin in Adult Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NCT03533283) | Hoffmann-La Roche | 2018-05-08 |
| Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria With Inadequate Response to Eculizumab (NCT03472885) | Alexion Pharmaceuticals, Inc. | 2018-05-08 |
| Study to Evaluate Botulinum Neurotoxin Serotype E (EB-001) in Reducing Musculoskeletal Pain in Abdominoplasty (NCT03429556) | Allergan | 2018-05-08 |
| Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia (NCT03476330) | Children's Hospital Medical Center, Cincinnati | 2018-05-08 |
| Therapeutic Potential for Intranasal Levodopa in Parkinson's Disease -Off Reversal (NCT03541356) | Impel Pharmaceuticals | 2018-05-08 |
| Post-operative Urinary Retention (POUR) Following Thoracic Surgery (NCT03609580) | Hackensack Meridian Health | 2018-05-07 |
| This Study is to Evaluate Safe and Effective Treatment Dose of OBI-888 in Patients With Locally Advanced or Metastatic Solid Tumors. (NCT03573544) | OBI Pharma, Inc | 2018-05-07 |
| Robotic Training for Stroke Neurorehabilitation (NCT02639390) | VA Office of Research and Development | 2018-05-07 |
| Ribociclib and Bicalutamide in AR+ TNBC (NCT03090165) | Kari Wisinski | 2018-05-07 |
| Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome (NCT03604198) | Corcept Therapeutics | 2018-05-07 |
| Tipifarnib in Advanced Squamous NSCLC With Oncogen HRAS MutAtionS (NCT03496766) | Spanish Lung Cancer Group | 2018-05-07 |
| Prilocaine or Bupivacaine for Spinal Anesthesiain Pregnant (NCT03433976) | University Hospital, Montpellier | 2018-05-07 |
| Study of ASTX029 in Subjects With Advanced Solid Tumors (NCT03520075) | Taiho Oncology, Inc. | 2018-05-07 |
| NCT Neuro Master Match - N²M² (NOA-20) (NCT03158389) | University Hospital Heidelberg | 2018-05-07 |
| Nivolumab, Cabozantinib S-Malate, and Ipilimumab in Treating Patients With Recurrent Stage IV Non-small Cell Lung Cancer (NCT03468985) | National Cancer Institute (NCI) | 2018-05-07 |